Clinical trial · Observational

Combined HCC-MFCCC

Survival After Hepatectomy for Combined Hepatocellular Cholagiocarcinoma

NCT03178409CI-TRIAL-00027997completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Combined hepatocellular and mass-forming cholangiocarcinoma (cHCC-MFCCC) is a rare tumor. The aim of this study was the analysis of the outcome comparing such tumor with classic hepatocellular carcinoma (HCC) and mass-forming cholangiocarcinoma (MFCCC).

Conditions

Conditions (4)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Cholangiocarcinoma	Cholangiocarcinoma	ONTOLOGY_EXACT	0.98
Hepatocellular Carcinoma	Hepatocellular Carcinoma	ONTOLOGY_EXACT	0.98
Liver Carcinoma	Liver Carcinoma	ONTOLOGY_EXACT	0.98
Surgery	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
Hepatectomy	Procedure	—	UNRESOLVED

Design

Arms and outcomes

Arms (3)

label
cHCC-MFCCC
description
Patients affected by combined HCC-MFCCC
interventionNames
1. Procedure: Hepatectomy
label
HCC
description
Patients affected by classical HCC
interventionNames
1. Procedure: Hepatectomy
label
MFCCC
description
Patients affected by classical MFCCC
interventionNames
1. Procedure: Hepatectomy

Primary outcomes (1)

measure

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* positive histology for cHCC-MFCCC, HCC, and MFCCC
* complete clinical, surgical, pathological and follow-up data.

Exclusion Criteria:

* patients preoperatively treated with chemotherapy, radiofrequency ablation or trans-arterial therapies were excluded.
* patients operated for recurrent disease and/or with non-radical surgery
* patients with missing data were also excluded

References

Publications (0)

Data not yet available

No reference posted for this study.